The terminal event in the establishment of the haemochorial placenta in the human is the invasion of trophoblasts into the maternal vessels, a process in which trophoblasts interact directly with the vascular endothelium and degrade the vascular basement membrane and the tunica elastica of the vessels. To further understand this heterotypic cellular interaction, we investigated the expression by human trophoblasts of the vascular cell adhesion molecule platelet-endothelial cell adhesion molecule-1 (PECAM-1) as a possible mediator of the adhesive interaction between trophoblasts and endothelium. In vitro, human trophoblasts were found to express PECAM-1 mRNA and protein. Indirect immunofluorescence indicated a diffuse staining pattern, which was most intense in a subpopulation of trophoblast cells. Co-incubation of trophoblasts with endothelial cells showed interaction between these two cell types with strong expression of PECAM-1 at points of trophoblast-endothelial cell contact, suggesting that this cell adhesion molecule participates in this heterotypic cell interaction. Immunohistochemical localization of PECAM-1 in chorionic villi and first trimester implantation sites showed that, in vivo, only extravillous interstitial and endovascular trophoblasts were positive. In first trimester placentae, villous trophoblast and extravillous trophoblast in other locations than around or within the decidual vessels did not express this molecule. In term placentae, villous trophoblast did not express these adhesion molecules except for two specimens examined. This study demonstrates that PECAM-1 is expressed by a subset of human trophoblasts in vitro and in vivo. Its tissue localization suggests that PECAM-1 is important in mediating the adhesive interaction between trophoblasts and maternal vascular endothelium during the process of haemochorial placentation. Regulation of PECAM-1 expression by human trophoblasts may play a critical role in normal and abnormal vascular invasion during implantation and placentation.
Introduction
In the human, the placenta is haemochorial. This type of placentation involves complex interactions of the chorionic epithelium, i.e. the trophoblast, and the uterine vasculature. One of the earliest events in the establishment of haemochorial placentation is the invasion of the maternal decidual vessels by the syncytiotrophoblasts surrounding the implanting blastocyst. As a result, maternal blood flows into a lacunary system that eventually develops into a large intervillous space, where developing placental villi covered by trophoblast float freely. The trophoblast layer provides the interface between maternal and fetal blood that is critical for fetal gas exchange, as well as for the exchange of nutrients and waste products. In this setting, the syncytiotrophoblast comes into direct contact with maternal blood, assuming an endothelial-like function.
The interaction of the trophoblast with the maternal vessels is not limited to these initial events. To provide anchorage, some villi break through the outermost shell surrounding the intervillous space and cytotrophoblast columns invade the maternal decidual stroma. It has become clear that the extravillous trophoblast is gradually transformed into a mesenchy-mal-like cell with properties that are very different from those of the epithelial-like villous trophoblast. An increasing weight of evidence strongly suggests that the extravillous pathway of trophoblast differentiation can be subdivided into three stages: the proximal extravillous trophoblasts originating from the anchoring villi; the deep interstitial extravillous trophoblasts invading the decidual stroma and the myometrium; and the endovascular trophoblasts, which assume endothelial-like characteristics (Damsky et al., 1994; Burrows et al., 1996; Zhou et al., 1997a) . Invading trophoblast cells colonize the arterial wall of the spiral arteries, where they digest the internal elastic lamina and disrupt the tunica media (DeWolf et al., 1980) . These modifications provide the means by which the lowcapacity/high-resistance spiral arteries supplying the maternal decidua are transformed into high-capacity/low-resistance vessels supporting the utero-placental circulation. It has been postulated that the trophoblast invades the uterine tissue and vasculature in two 'waves'. During the first trimester of pregnancy, the invasion is mainly contained within the decidual segments of the spiral arteries, while in the second trimester it extends into their intramyometrial segments (Robertson et al., 1975; Pijnenborg et al., 1983) . This invasion may occur via endoluminal upstream migration of the trophoblast or through trans-stromal migration of the extravillous trophoblast and subsequent penetration of the arterial wall (Khong et al., 1986) . The molecular mechanisms underlying this complex morphogenetic process are being gradually uncovered. During the process of extravillous differentiation, the trophoblasts down-regulate specific extracellular matrix proteins and cell adhesion molecules, while they up-regulate others (Damsky et al., 1994) . They also acquire properties of invasive cells, secreting proteolytic enzymes that are capable of degrading the decidual stroma (Tabibzadeh and Babaknia, 1995; Bischof and Campana, 1996) . The interaction of the trophoblasts with components of the vascular compartment, and particularly with the endothelium, are complex and require the up-regulation of specific adhesion molecules capable of mediating this heterotypic binding. The molecular aspects of this interaction are still poorly characterized.
Platelet endothelial cell adhesion molecule-1 (PECAM-1) or cluster designation (CD)31, a member of the immunoglobulin (Ig) gene superfamily, is a transmembrane glycoprotein of~130 kDa (Newman et al., 1990; DeLisser et al., 1994a) . This molecule is widely expressed by cells associated with the vascular compartment, such as endothelium, platelets, monocytes, neutrophils and lymphocytes, and appears very early during development of the vascular system (Baldwin et al., 1994; DeLisser et al., 1994b) . Although all of the physiological roles of PECAM-1 have not yet been determined, evidence to date indicates that PECAM-1 functions as a cell adhesion molecule in at least two capacities. Its localization to cell-cell borders of adjacent endothelial cells (Muller et al., 1989) suggests that PECAM-1 may play an important role in endothelial cell homotypic interactions in the process of angiogenesis. This is further confirmed by the ability of antibodies against PECAM-1 to disrupt the formation of endothelial cell-cell interactions (Albelda et al., 1990) . In addition, experiments both in vitro and in vivo have implicated PECAM-1 in leukocyte-endothelial interactions underlying the process of leukocyte transmigration through the vessel wall during inflammation (Muller et al., 1993; Vaporician et al., 1993) . In fact, immunoneutralization of PECAM-1 blocks neutrophil and monocyte migration through endothelium (DeLisser et al., 1994b) .
Given the intimate interaction of trophoblasts with the endothelium during placentation, we studied the expression of PECAM-1 in human trophoblasts in vivo and in vitro. Our results indicate that PECAM-1 is, expressed in vivo and in vitro by human trophoblasts and appears to be involved in the interaction between trophoblasts and endothelial cells.
Materials and methods

Reagents, antibodies and peptides
All reagents were of analytical grade and were purchased from Sigma Chemical Company (St Louis, MO, USA), unless otherwise stated. Monoclonal antibodies 4G6 (DeLisser et al., 1994a) , anti-CD31 5.6E clone JC/70A (Dako, Carpinteria, CA, USA) and anti-CD31 clone (AMAC, Westbrook, ME, USA) as well as a polyclonal antibody raised against human PECAM-1 (Albelda, et al., 1991) were used at a concentration of 20 µg/ml of purified immunoglobulin G (IgG). Monoclonal antibody CAM 5.2 (Becton Dickinson, Mountain View, CA, USA) recognizing cytokeratins 8 and 18 of M r 39 and 43 kDa (Makin et al., 1984) was used at a dilution 1:20. A polyclonal antihuman placental lactogen (hPL) antibody (Dako) was used at a dilution of 1:350. A polyclonal antibody against factor VIII (Dako) was used at a dilution of 1:100. Monoclonal antibody RH1-38 against CD18 (Blanchard et al., 1990 ) was used at a dilution of 10 µg/ml in double staining studies for recognition of leukocytes in trophoblast primary cultures.
Tissue preparations
Third trimester placentae were obtained immediately after uncomplicated vaginal deliveries or elective Caesarean sections. First trimester implantation sites containing floating villi, anchoring villi, decidua and, occasionally, superficial myometrium, were obtained from several cases of cornual or interstitial pregnancies at 8-12 weeks of estimated gestational age that required emergency hysterectomy. Implantation sites were also obtained from an eighth week intrauterine pregnancy discovered in a patient undergoing radical hysterectomy for invasive carcinoma of the cervix, and from multiple first trimester dilatation and curettage specimens. None of the surgical procedures were performed for research purposes. The use of residual tissue (i.e. excess tissue after the surgical pathology laboratory obtained the necessary tissue for diagnostic purposes) in the present studies was approved by the Institutional Review Board of the University of Pennsylvania. Tissues were copiously washed with ice-cold phosphate buffered saline (PBS), embedded in Tissuetek 4583 OCT cryomedium (Miles Inc., Elkhart, IN, USA), and snap-frozen in liquid nitrogen and stored at -80°C. First trimester implantation sites were also obtained from formalin-fixed paraffin-embedded archival material from cornual or interstitial ectopic pregnancies.
Cell preparation and culture
Cytotrophoblasts were prepared from human placentae as previously described (Kliman et al., 1986) . Briefly, chorionic villi were minced and digested with trypsin and DNAase in calcium-and magnesiumfree medium followed by centrifugation on a 5-70% Percoll gradient at 500 g. Cell banding at a density of 1.048-1.065 g/ml produced a highly enriched (~95% pure) and viable preparation of cytotrophoblasts. This population of cells was plated on Nunclon Delta (Nunc, Roskilde, Denmark) tissue culture dishes at a density of 3ϫ10 5 cells/ cm 2 in the presence of 20% heat-inactivated fetal calf serum (FCS). Cells were cultured with Dulbecco's modified Eagle's medium (DMEM) containing 25 mM glucose, 25 mM HEPES, 60 µg/100ml L-glutamine and 50 µg/ml gentamycin. Under these conditions, trophoblasts flatten, migrate, aggregate and form syncytia in a time-dependent manner (Kao et al., 1988) . Human umbilical vein endothelial (HUVE) cells were prepared as previously described (Albelda et al., 1989) and plated at a density of 3ϫ10 5 cells/cm 2 in the presence of M199 medium supplemented with 20% FCS, endothelial cell growth factor, and heparin. Culture dishes were precoated with 2% gelatin for the growth of HUVE cells. The A549 lung carcinoma cell line (used as a negative control) was purchased from the American Type Culture Collection (Bethesda, MD, USA).
For immunofluorescence studies, cells were plated on 2% gelatinprecoated glass coverslips (2ϫ2 cm), placed in 6-well plates (Nunclon Delta) at a density of 1.5ϫ10 5 cells/cm 2 in the above medium enriched with 20% normal FCS. For co-incubation studies with endothelial cells, the above medium (20% FCS-DMEM) were mixed with medium M199 supplemented with 20% FCS, endothelial cell growth factor, and heparin (Albelda et al., 1989) to support adhesion and growth of HUVE cells, at a 50:50 vol:vol ratio.
Indirect immunofluorescence
Cells grown on coverslips were washed twice in prewarmed (37°C) DMEM and twice in prewarmed PBS containing 1.5 mM calcium and then fixed with 100% methanol at -20°C for 5 min. Fixed cells were washed in PBS and incubated in 10% normal goat serum for single immunofluorescence studies for 30 min at room temperature. For double immunofluorescence studies, cells were incubated in 10% goat serum-10% swine serum. Incubation with the primary antibodies (diluted in the same medium) followed for 2 h. Cells were then washed thoroughly with PBS-0.4% bovine serum albumin (BSA) and incubated with fluorescein-conjugated goat anti-mouse IgG and/ or rhodamine-conjugated swine anti-rabbit IgG secondary antibodies (Jackson Immunoresearch Laboratories Inc., West Groove, PA, USA) at a dilution of 1:100 in PBS-0.4% BSA for 30 min. Coverslips were mounted on glass slides with Fluoromount G (Fisher Scientific, Malvern, PA, USA) containing 1,4-diazabicyclo(2.2.2)octane (DABCO) (Polysciences Inc., Warrington, PA, USA), to stabilize fluorescence. Cells were examined and photographed with a Zeiss microscope.
For frozen placental tissue, 6-8 µm cryotome tissue sections were applied on poly-L-lysine pretreated glass slides and fixed with methanol (3 min) and acetone (1 min) at -20°C. Paraffinembedded tissue sections of 5 µm were deparaffinized at 70°C and treated with prewarmed pepsin (0.65 mg/ml in PBS) at 40°C for 20 min. Sections were incubated in 0.1% sodium borohydride-PBS for 2 h at room temperature, to reduce tissue endogenous fluorescence. Sections were then blocked with 25% goat serum-25% swine serum-4% BSA in PBS. Primary antibodies were diluted in the same buffer and employed for indirect immunofluorescent studies as previously described . Sections were mounted with media as above. Double-staining immunofluorescence was carried out combining the polyclonal anti-PECAM-1 antibody with the monoclonal antibody against cytokeratins or the monoclonal anti-CD31 antibodies with the polyclonal antibodies raised against hPL or against factor VIII.
Protein preparation
Immunoblotting Trophoblast cells in monolayer cultures grown for variable times were placed on ice and washed twice with ice-cold PBS containing 2 mM phenylmethylsulphonyl fluoride (PMSF). For immunoblotting, cells were harvested in 1 ml of 5 mM ethylenediaminotetraacetic acid (EDTA)-PBS containing 2 mM PMSF at 4°C by scraping off the plates with a cell scraper (Marsh, Rochester, NY, USA) and were centrifuged for 5 min at 16 000 g in a microfuge at 4°C. The cell pellets were lysed with 0.1 ml PBS lysis buffer containing 0.01 M Tris acetate (pH 8.0), 0.5% Nonidet P-40, 0.5 mM Ca 2ϩ (TNC) as well as protease inhibitors (2 mM PMSF, 2 µg/ml antipain, 10 µg/ml benzamidine, 2 µg/ml aprotinin, 1 µg/ml leupeptin, 1 µg/ ml pepstatin A and 1 mg/ml chymostatin). Following this procedure, pellets were dissolved through a 28 1 2 gauge needle (Becton-Dickinson, NJ, USA), and incubated on ice for 20 min with occasional vortexing. The cell extracts were centrifuged at 16 000 g in the microfuge at 4°C for 30 min. Supernatants were snap-frozen and kept in -80°C until utilization. Protein concentrations in the cell extracts were evaluated according to Bradford (1976) . Samples (150 µg protein) were heated at 100°C for 5 min and underwent sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) according to Laemmli (1970) in 7% gels in non-reducing conditions. The proteins were electrophoretically transferred to nitrocellulose paper 359 (BA-S NC; Schleicher and Schuell, Keene, NH, USA) using the procedure of Towbin et al. (1979) . The blots were washed twice in Tris-buffered saline (TBS; 20 mM Tris, 500 mM NaCl, pH 7.5) for 10 min, and then incubated in 5% non-fat dry milk (Carnation) TBS for 1 h. The blots were incubated in the polyclonal anti-PECAM-1 antibody (25 µg/ml) for 2 h, washed with TBS-Tween [50 mM Tris (pH 7.5), 171 mM NaCl, 0.05% (v/v) Tween 20] for 5 min three times and incubated with alkaline phosphatase anti-rabbit antibody (Promega, Madison, WI, USA) in 1:7500 dilution for 1 h. Blots were washed again with TBS-Tween for 5 min three times, equilibrated against alkaline phosphatase buffer (APB) containing 10 mM Tris (pH 9.5), 100 mM NaCl and 5 mM MgCl 2 for 5 min and finally developed with nitroblue tetrazolium (NBT, Promega) and 5Ј,Br-4Ј,Cl-3Ј,indolyl-phosphate (BCIP, Promega) 0.66% and 0.33% (v/v), respectively, in APB.
Immunoprecipitation
For immunoprecipitation, monolayers of cells were starved at selected time points in methionine-free DMEM containing 1% dialysed FCS for 2 h and then incubated in methionine-free DMEM with 1% dialysed FCS and 300 mCi/ml [ 35 S]cysteine-methionine (Express, NEN â , Du Pont, Boston, MA, USA) for 12 h. Cells were extracted with the same method as for immunoblotting, except that the cells were lysed directly in the plates in 200 µl TNC lysis buffer. Cell extracts were precleared with protein A Sepharose beads (Pharmacia, Uppsala, Sweden) in PBS containing 250 mM NaCl and 0.3% BSA. The radioactive counts/ml of precleared extracts were estimated by trichloroacetic acid (TCA) precipitation. Volumes containing equal TCA-precipitable counts from all samples were incubated with 50 µl of anti-PECAM-1 monoclonal antibody 4G6 (10 µg/ml) and 100 ml of 20% protein A Sepharose beads-PBS for 3 h at 4°C. The immunoprecipitated extracts were run in 7% SDS-PAGE under nonreducing conditions, after being heated at 100°C for 5 min. Gels were fixed in 10% (w/v) TCA, 10% (v/v) acetic acid, 30% (v/v) methanol; washed three times in deionized water for 30 min; treated with 1 M sodium salicylate, 1% (v/v) glycerol (pH 5) for 30 min; dried under vacuum and exposed to X-OMAT AR™ (Kodak, Rochester, NY, USA) film.
RNA isolation, electrophoresis and Northern blotting
Total RNA was extracted from cultured trophoblasts, HUVE, and A549 cells with the guanidine isothiocyanate (GITC) method (Maniatis et al., 1982) . Briefly, cell monolayers were rinsed with ice-cold PBS three times and lysed with 4M GITC (Boerhinger Mannheim, IN, USA), 0.1 M Tris (pH 7.5), 1% β-mercaptoethanol. The lysates were homogenized in a Polytron homogenizer (Kinematica AG, Luzern, Switzerland) at medium speed for 10 s five times, loaded on 5.7 M CsCl, 0.01M EDTA (pH 7.5) and centrifuged at 35 000 r.p.m. for 24 h (Beckman L3-50; SW 50.1 rotor; Beckman Instruments; Fullerton, CA, USA). The pellet was washed with 70% ethanol, dried, and dissolved in 200 µl of diethyl pyrocarbonate (DEPC)-treated water. RNA was reprecipitated with 100% ethanol, washed in 70% ethanol, dried, and dissolved in DEPC-treated water. RNA was quantified by absorbency at 260 nm and stored at -80°C. For Northern blot analysis, total RNA (15 µg) was separated on a 0.8% agarose-2.2 M formaldehyde gel and transferred to Zeta-probe nylon membrane (Bio-rad, Mellville, NY, USA). The membrane was hybridized with a randomly-primed PECAM-1 probe in 0.5 M sodium phosphate buffer (pH 7.2, 7% SDS, 1 mM EDTA) at 60°C for 20 h and washed twice for 30 min in 40 mM sodium phosphate buffer, 2% SDS, at 65°C. Blots were exposed to X-OMAT ARä (Kodak) film for 1-7 days. There is a clear, but faint, signal from the trophoblasts cultured for 96 h (lane 2). This gel was exposed to X-ray film for 4 days. (C) Because of the large disparity in intensity between the trophoblast and endothelial cell message levels, the gels were re-exposed to X-ray film for different lengths of time. The characteristic doublet of PECAM-1 message is more easily seen after a longer (7 day) photographic exposure (lane 2). This message can be more clearly compared with the endothelial cell blot that was exposed for a shorter period of time (1 day of exposure) (D, lane 4).
Results
PECAM-1 mRNA and protein expression by human trophoblasts
To determine if PECAM-1 was expressed by trophoblasts, mononuclear cytrophoblasts were isolated by enzymatic dispersion of chorionic villi and placed in monolayer culture. These cells in culture form multicellular aggregates, some of which proceed to fuse and form multinucleated syncytia (Kliman et al., 1986; Coutifaris and Coukos, 1994) . Cells at various times after isolation were analysed for PECAM-1 mRNA and protein expression.
To analyse for the presence of PECAM-1 message, RNA was extracted from trophoblasts and human endothelial cells and hybridized with PECAM-1 cDNA. No message was detectable in freshly isolated trophoblasts at 0 h ( Figure 1B, Figure 2 . Time course of platelet-endothelial cell adhesion molecule-1 (PECAM-1) expressed by human trophoblasts in vitro as assessed by immunoblotting. Human trophoblasts were isolated, cultured, and cellular proteins were extracted as described in the text. Protein was transferred to nitrocellulose and exposed to a polyclonal anti-PECAM-1 antibody. Positively reacting protein was noted at a molecular weight (MW) range between 100 and 120 kDa with similar electrophoretic mobility as the control protein from endothelial cells (E). Note the time-dependent increase in the amount of PECAM-1 protein during the differentiation of the cells in vitro over 96 h of culture. lane 1). In contrast, a 4.1 and 3.2 kb doublet was detectable in trophoblasts cultured for 96 h and in HUVE cells ( Figure  1B, lanes 2 and 4) . The abundance of PECAM-1 mRNA was much higher in HUVE cells than in human trophoblast cells, however.
Given that the abundance of PECAM-1 mRNA in human trophoblast cells was too low at 24 h of culture, immunoblotting and immunoprecipitation studies were also performed to assess PECAM-1 expression at the protein level. Freshly isolated mononuclear cytotrophoblasts showed no expression of PECAM-1, in keeping with our immunohistochemistry data showing no expression of PECAM-1 in villous cytotrophoblast (see below). However, by 24 h in culture, expression of PECAM-1 protein could be clearly demonstrated (Figure 2 ). An immunoprecipitation study (Figure 3) confirmed the denovo synthesis of PECAM-1 by 24 h in vitro. Both the immunoblotting and immunoprecipitation studies showed that the protein exhibited similar electrophoretic mobility as PECAM-1 extracted from HUVE cells in culture. Moreover, the immunoprecipitation experiment confirmed that HUVE cells expressed higher amounts of PECAM-1 in vitro than cultures of human trophoblasts.
We performed indirect immunofluorescence experiments in order to determine the localization of PECAM-1 protein on differentiating trophoblasts and to rule out the possibility that contaminating cell types were responsible for the PECAM-1 detected by biochemical techniques. Staining with anti-PECAM-1 antibodies at 24 h of culture indicated that a subpopulation of mononuclear cells were strongly positive for PECAM-1 (Figure 4 ). These PECAM-1-expressing cells were confirmed as trophoblasts using immunohistochemical markers: they stained positively for cytokeratin or hPL (consistent with trophoblasts) and negatively for CD18 (ruling out macrophages) and factor VIII (ruling out endothelial cells). At 72 h, Ͻ1% of the cells were factor VIII positive and Ͻ5% were CD18 positive (data not shown). Examination of syncytia formed at later times in culture indicated that some were strongly positive for PECAM-1, while others were negative. Identical results were obtained utilizing all three different monoclonal antibodies as well as the polyclonal antibody against PECAM-1 in multiple experiments.
PECAM-1 Localization at cell-cell borders during coincubation of human trophoblasts with HUVE cells
PECAM-1 mediates endothelial-endothelial homotypic interactions as well as heterotypic interactions of the endothelium with other cell types such as activated leukocytes; it mediates such cellular interactions via its ability to localize to the cellcell borders of adjacent endothelial cells and leukocytes (Muller et al., 1989) . In our primary culture experiments, PECAM-1 immunolocalized diffusely within the cytoplasm of trophoblast . Note that PECAM-1 negative trophoblasts t 2 and t 3 do not establish cell-cell contacts with any HUVE cells, while a focal interaction between a PECAM-1 possible trophoblast cell (t 1 ) and an endothelial cell can be appreciated. Also note that in the presence of endothelial cells, PECAM-1 is redistributed at the cell surface.
cells in the absence of endothelial cells. Moreover, no immunoreactivity was identified on the cell surface at points of trophoblast-trophoblast interaction, indicating that this adhesion molecule is not implicated in homotypic interactions between trophoblast cells. To determine if PECAM-1 was involved in trophoblast-endothelial interactions, co-incubation experiments were performed. Indirect immunofluorescence (Figures 5 and 6 ) indicated that interactions with endothelial cells were limited to trophoblast cells that expressed PECAM-1, while trophoblasts that lacked expression of PECAM-1 did not show any contacts with the endothelial cells. Remarkably, in the presence of endothelial cells, immunolocalization of PECAM-1 was mainly observed at the cell surface and was polarized towards points of trophoblast-endothelial cell-cell contact ( Figure 6B-D, arrowheads) . The immunolocalization of PECAM-1 at points of cell-cell contact was similar to that observed between endothelial cells ( Figure 6C , arrow). The identity of the different cell types was determined by double labelling with anti-cytokeratin primary antibodies ( Figure 6E ).
PECAM-1 expression by specific subsets of trophoblasts in vivo
In human chorionic villi from first, second and third trimester placentae, strong expression of PECAM-1 was seen in the fetal capillary endothelial cells. There was complete absence of PECAM-1 immunostaining in the villous trophoblast layer in all first trimester placentae ( Figure 7B ) and the vast majority of the term placentae examined ( Figure 7D ). In these specimens, double immunostaining with an anti-cytokeratin antibody clearly indicated that the villous cyto-or syncytiotrophoblasts did not express this cell adhesion molecule. However, we identified two term placentae with strong PECAM-1 immunostaining of the syncytiotrophoblast layer ( Figure 7E ).
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Cytokeratin positive cells of the trophoblastic 'shell' that covers the decidual surface of the intervillous spaces did not stain for PECAM-1 (not shown).
Staining of first trimester human implantation sites confirmed our in-vitro data and revealed a pattern of developmental regulation of the molecule during trophoblast differentiation along the extravillous pathway. Extravillous trophoblasts were followed from the proximal part of the cytotrophoblastic columns of anchoring villi until the myometrium. Interstitial trophoblasts were seen to invade deeply in the decidual stroma as well to colonize the decidual vessels. These cells were identified as cytokeratin-positive or hPL-positive cells. PECAM-1 was absent in the proximal columns originating from the anchoring villi ( Figure 7G ). By contrast, in the same implantation site sections, we observed isolated or groups of wandering trophoblast cells in the decidual stroma (hPL positive or cytokeratin positive) that expressed PECAM-1. However, the strongest expression was seen by trophoblasts that were located within decidual vessels (Figure 8 ). Several stages of transformation of the decidual vascular tree were observed. In some vessels, the lumen was entirely covered by a continuous layer of factor VIII-positive endothelial cells. These cells displayed a strong PECAM-1 immunoreactivity. Some other vessels were entirely colonized by trophoblast cells that were forming a continuous layer covering their luminal surface. These endovascular trophoblast cells also expressed PECAM-1 strongly and uniformly. Finally, some Only fetal capillaries in the core of the villi stain for PECAM-1 at the level of the endothelial cells. In first trimester anchoring villi (F), the cytotrophoblasts comprising the cell column of the anchoring villus are also negative for PECAM-1 (G), which again is present in the vessels of the villus. (E) Third trimester villi from one patient showing intense immunostaining for PECAM-1 at the apex of the syncytiotrophoblast layer. Bar ϭ 100 µm (A-D, F, G) , bar ϭ 10 µm (E).
partially transformed vessels were seen, where both trophoblast and endothelial cells were present on the luminal surface ( Figure 9 ). In these sites, trophoblast cells were observed to come into close contact with endothelial cells, and PECAM-1 could be clearly identified at the areas of cell-cell contact between the two different cell types. The unquestionable identity of these cells as trophoblasts was determined by immunostaining with cytokeratin or hPL. Identical results were obtained utilizing all three different monoclonal antibodies as well as the polyclonal antibody against PECAM-1 in multiple experiments and with multiple specimens.
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Discussion
This study shows that the cell adhesion molecule PECAM-1, which is known to mediate adhesion between several vascular cells, as well as cells of myeloid origin, is also expressed by a subpopulation of human trophoblasts. The human trophoblast interacts with the endometrial epithelium during embryo implantation and subsequently invades the basement membrane migrating through the endometrial stroma by mechanisms that are at present incompletely understood. In its final stages of invasion, the trophoblasts degrade the vascular basement membrane and come into direct contact with the maternal vascular endothelial cells, finally replacing them. Colonization of the spiral arteries by trophoblasts ultimately leads to disruption of the tunica muscularis and elastica and deposition of fibrin within the vascular wall. This process is fundamental in the establishment of a low resistance vascular meshwork which provides increasing amounts of maternal blood for the support of the growing fetus and placenta (Robertson et al., 1975; DeWolf et al., 1980; Pijnenborg et al., 1983; Bischof and Campana, 1996) .
In the present study, we have determined that PECAM-1 is one cell surface component expressed by human trophoblasts that mediates the adhesion of these cells with the vascular endothelium. Our initial studies used freshly isolated human cytotrophoblasts. These cells differentiate in vitro into trophoblasts that display significant motility and that possess various characteristics of extravillous trophoblasts, such as expression of plasminogen activator inhibitor-1 (PAI-1), oncofetal fibronectin (Feinberg et al., 1989 (Feinberg et al., , 1991 and α5 integrin subunit (Coutifaris and Coukos, 1994) . Freshly isolated cells expressed no PECAM-1 at the protein or mRNA level, in keeping with the finding that villous cytotrophoblasts do not express this molecule. Nevertheless, expression of PECAM-1 at both the mRNA and protein levels was up-regulated in these cells in culture. HUVE cells expressed significantly higher amounts of PECAM-1 mRNA and protein than trophoblasts. Indirect immunofluorescence studies showed that this was attributable to the fact that only a fraction of trophoblasts expressed this cell adhesion molecule in vitro. It is currently unclear why only certain cells expressed PECAM-1, but this observation suggests that only one subpopulation of trophoblast cells possess the ability to commit themselves towards the endovascular differentiation pathway. Our in-vitro studies also demonstrated that, although PECAM-1 expression appears to be constitutive in this subpopulation of trophoblasts, the molecule only migrates to the cell surface in the presence of endothelial cells. Moreover PECAM-1 localization becomes polarized in sites of trophoblast-endothelial cell contact, suggesting its implication in heterotypic cell binding. Impressively, this molecule is restricted to the vascular compartment and does not appear to mediate homotypic trophoblast-trophoblast contacts, which appear to be largely mediated by E-cadherin (Coutifaris et al., 1991) .
We extended our studies by examining first trimester implantation sites. PECAM-1 could be clearly identified on interstitial trophoblasts in the proximity of decidual vessels or colonizing decidual vessels. PECAM-1 localized mainly to the trophoblast cell surface also in vivo, and we could observe a polarization of the molecule towards points of trophoblastendothelial interaction. It appears that trophoblast cells upregulate this molecule once they detach from the cytotrophoblastic column and approach decidual vessels. Our in-vivo and in-vitro data strongly suggest that trophoblast cells utilize this molecule to interact with the endothelium. Moreover, endovascular trophoblasts maintain expression of the molecule following complete colonization of a segment of a vessel. The process of vascular colonization by the trophoblast may occur via the endoluminal route, whereby the trophoblast wave extends into the arterial decidual tree, departing from the orifices of the spiral arterioles into the lacunary space, as might be the case in the macaque (Blankenship et al., 1997) . Alternatively, invasion of the vascular tree may occur via an 364 interstitial route, whereby trophoblast cells invade the decidual stroma and subsequently brake through the wall of the arterioles. Certainly, the path of least resistance appears to be the endoluminal route. In that regard, it was interesting to see in our sections isolated endoluminal PECAM-1 positive trophoblast cells adhering to the luminal surface of endothelial cells in sections of vessels where the endothelial layer was not disrupted and there was no evidence of trophoblasts in the wall of the vessel. This observation would favour the endoluminal route of invasion. If this were the case, molecules such PECAM-1 that mediate the trophoblast-endothelial interaction would play a key role in the biology of implantation. Other candidate molecules include ICAM-1 (Burrows et al., 1994) , E-selectin, VE-cadherin, vascular endothelial cell adhesion molecule-1 (VCAM-1) and the α4β1 and αvβ3 integrins (Zhou Piali et al., 1995) . This entire repertoire of endovascular compartment adhesion molecules appears to be up-regulated by endovascular trophoblasts, reflecting the complexity of the process. On the other hand, we observed partially transformed vessels with trophoblast cells invading the decidua around the vessels as well as the wall of the vessels and reaching the luminal surface, but there was no evidence of endoluminal clusters of cells or isolated trophoblast cells. These observations would support the interstitial route of invasion. In this case, molecules mediating the interaction of the trophoblasts with the decidual stroma, acting in concert with proteolytic enzymes, would assume a leading role in spiral colonization. It may be possible that both mechanisms occur and that they overlap to ensure completion of placentation.
The villous syncytiotrophoblast is also in direct contact with the maternal blood and is known to express several molecules that are typically expressed by the endothelium, such as the transferrin receptor (Gatter et al., 1983) , thrombomodulin (Maruyama et al., 1985) and endoglin (Gougos et al., 1992) . Nevertheless, the villous syncytiotrophoblast does not appear to express PECAM-1 routinely. This would further support the concept that expression of PECAM-1 by the trophoblast specifically occurs in the context of trophoblast-endothelial interaction during decidual colonization. However, we were 365 able to show PECAM-1 immunoreactivity in the apical border of the syncytiotrophoblast in two placentae examined. Despite extensive investigation in multiple specimens, we could not identify PECAM-1 expression in any other case. Interestingly, this pattern of PECAM-1 expression by the villous syncytiotrophoblast is typical of the macaque (Blankenship and Enders, 1997) . Certainly, we showed that the human syncytiotrophoblast also possesses the ability to express PECAM-1 in vitro. The significance of this finding remains obscure.
The pattern of PECAM-1 expression in vivo, as well as the migration of the molecule to the cell surface observed in vitro, indicates that this molecule is developmentally regulated. The mechanisms of its regulation remain unclear. Endothelial cell adhesion molecules such as ICAM-1 are known to be under inflammatory cytokine control (Pober, 1986) . Moreover, angiogenetic factors such as vascular/endothelial growth factor (VEGF) may play a role. It is clear that successful and adequate vascular invasion by trophoblasts during placentation in the human is critical, not only in the successful establishment of pregnancy but also in the normal maintenance of pregnancy (Gerretsen et al., 1983; Khong et al., 1986; Redman, 1991 ). An aberrant invasion of the trophoblasts in the maternal decidua and myometrium with lack of spiral artery invasion has been postulated to lead to a deficient development of the uteroplacental circulation during the second trimester, ultimately leading to the development of gestational complications such as pre-eclampsia or intrauterine growth restriction (IUGR). If PECAM-1 is a key molecule governing the interactions of the trophoblasts with the maternal vascular structures, it can be postulated that this molecule may play a role in the pathophysiology of placentation abnormalities. The observations by Zhou et al. (1997b) lend support to this hypothesis. Nevertheless, peripartum treatment of pre-eclamptic patients with high doses of magnesium sulphate and/or antihypertensive medications as well as oxytocin for induction of labour should provide caution in the interpretation of the results. Lyall et al. (1995) failed to identify any differences in PECAM expression, as assessed by immunohistochemistry, between placentae from normal pregnancies and pregnancies complicated by preeclampsia with or without IUGR or by IUGR alone.
In summary, we have demonstrated that subpopulations of the human trophoblast express PECAM-1, a molecule known to be expressed by components of the myeloid progeny as well as by the endothelium. This observation attests to the versatility of the trophoblast cell, which assumes features of an epithelial, mesenchymal or endovascular cell, depending on its location. It also opens a line of investigation for the understanding of the physiology and pathophysiology of human placentation. Further work understanding the function and the regulation of expression of this cell adhesion molecule may elucidate the molecular basis of abnormal placentation such as the one seen in pre-eclampsia and IUGR.
